Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F

Journal of Medical Investigation

Volumn 57, Issue 1-2, 2010, Pages 89-94

  Nagao, Tamiko ^a   Yamashita, Tomoki ^a   Miyake, Ariko ^a   Uchiyama, Tsuneo ^a   Nomaguchi, Masako ^a   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

APOBEC3F; APOBEC3G; HIV 1; Vif

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; VIF PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POINT MUTATION; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VIRION; VIROGENESIS; VIRUS ACTIVATION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS NEUTRALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77749298569     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.57.89     Document Type: Article

References (22)

1. Holmes RK, Malim MH, Bishop KN : APOBEC-mediated viral restriction : not simply editing? Trends Biochem Sci 32 : 118-128, 2007.
2. He Z, Zhang W, Chen G., Xu R, Yu XF : Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol 381 : 1000-1011, 2008.
3. Yamashita T, Kamada K, Hatcho K, Adachi A, Nomaguchi M : Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F. Microbes Infect 10 : 1142-1149, 2008.
4. Yamashita T, Nomaguchi M, Miyake A, Uchiyama T, Adachi A : Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity. Microbes Infect (in press)
5. Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF : Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. J Virol 80 : 3112-3115, 2006.
6. Russel RA, Pathak VK : Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J Virol 81 : 8201-8210, 2007.
7. Mehle A, Wilson H, Zhang C, Brazier AJ, McPike M, Pery E, Gabuzda D : Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding. J Virol 81 : 13235-13241, 2007.
8. Pery E, Rajendran K, Brazier AJ, Gabuzda D : Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif. J Virol 83 : 2374-2381, 2009.
9. Dang Y, Wang X, Zhou T, York IA, Zheng YH : Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization. J Virol 83 : 8544-8552, 2009.
10. Chen G, He Z, Wang T, Xu R, Yu XF : A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J Virol 83 : 8674-8682, 2009.
11. Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu F : Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines Genes Dev 18 : 2867-2872, 2004.
12. Luo K, Xiao Z, Ehrlich E, Yu Y, Liu B, Zheng S, Yu XF : Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci USA 102 : 11444-11449, 2005.
13. Mehle A, Thomas ER, Rajendran KS, Gabuzda D : A zinc-binding region in Vif binds Cul5 and determines cullin selection. J Biol Chem 281 : 17259-65, 2006.
14. Xiao Z, Ehrlich E, Yu Y, Luo K, Wang T, Tian C, Yu XF : Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 349 : 290-299, 2006.
15. Lebkowski JS, Clancy S, Calos MP : Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature 12 : 169-171, 1985.
16. Kimpton J, Emerman M : Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 66 : 2232-2239, 1992.
17. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA : Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59 : 284-291, 1986.
18. Akari H, Fukumori T, Adachi A : Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions J Virol 74 : 4891-4893, 2000.
19. Fujita M, Sakurai A, Yoshida A, Matsumoto S, Miyaura M, Adachi A : Subtle mutations in the cysteine region of HIV-1 Vif drastically alter the viral replication phenotype. Microbes Infect 4 : 621-624, 2002.
20. + T cells. Nature 435 : 108-114, 2005.
21. Wang X, Dolan PT, Dang Y, Zheng YH : Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle. J Biol Chem 282 : 1585-1594, 2007.
22. Adachi A, Ono N, Sakai H, Ogawa K, Shibata R, Kiyomasu T, Masuike H, Ueda S : Generation and characterization of the human immunodeficiency virus type 1 mutants. Arch Virol 117 : 45-58, 1991.